SCHEMBL25752595

SCHEMBL25752595

Cc1ncccc1/C=C\I

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 1/20 0.38
▸ TRIM24 O15164 1/20 0.35
▸ TRIM33 Q9UPN9 1/20 0.35
▸ MKNK1 Q9BUB5 1/20 0.35
▸ MKNK2 Q9HBH9 1/20 0.35
▸ FGF23 Q9GZV9 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ NOS3 P29474 1/20 0.34
▸ NOS1 P29475 1/20 0.34
▸ NOS2 P35228 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ NFE2L2 Q16236 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17531171 0.81 APLNR (0.38) P2RX7TRIM24TRIM33MKNK1MKNK2
SCHEMBL11965841 0.81 APLNR (0.38) P2RX7TRIM24TRIM33MKNK1MKNK2
SCHEMBL17804028 0.79 TRIM24 (0.35) P2RX7TRIM24TRIM33FGF23NPC1
SCHEMBL9000369 0.78 FGF23 (0.41) P2RX7TRIM24TRIM33FGF23NPC1
SCHEMBL9117952 0.77 CA1 (0.50) P2RX7ALDH1A1KDM4EMAPT
SCHEMBL9756923 0.77 CA1 (0.50) P2RX7ALDH1A1KDM4EMAPT
SCHEMBL22931647 0.77 TRIM24 (0.36) TRIM24TRIM33NPC1HSP90AA1L3MBTL1
SCHEMBL25270872 0.76 NFE2L2 (0.36) P2RX7TRIM24TRIM33FGF23NPC1
SCHEMBL20312826 0.76 FGF23 (0.36) P2RX7TRIM24TRIM33MKNK1MKNK2
SCHEMBL31503106 0.76 NFE2L2 (0.36) P2RX7TRIM24TRIM33FGF23NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230197361-A1 CONDUCTIVE TWO-DIMENSIONAL (2D) COVALENT ORGANIC FRAMEWORKS (COFS) AND METHOD OF MAKING AN ELECTRODE MATERIAL UNIV KING ABDULLAH SCI & TECH (SA) 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230197361-A1 CONDUCTIVE TWO-DIMENSIONAL (2D) COVALENT ORGANIC FRAMEWORKS (COFS) AND METHOD OF MAKING AN ELECTRODE MATERIAL TET3, TET1, ALKBH2 P2RX7 1360/4885TRIM24 2507/4885TRIM33 3735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback